A new study demonstrates an advance in treating antibiotic-resistant infections in animals through personalized phage therapy.
MiMedx receives FDA warning letter over Axiofill manufacturing concerns
The FDA has highlighted deviations from current good manufacturing practice for MiMedx’s Axiofill, a placenta-based product which is under review regarding its legal classification. After